Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) — The “Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market – Global Forecast 2026-2032” report has been added to ResearchAndMarkets.com’s offering.
The Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market expanded from USD 98.08 billion in 2025 to USD 113.52 billion in 2026 and is projected to maintain a robust CAGR of 16.64%, reaching USD 288.22 billion by 2032.
The anti-counterfeit pharmaceuticals and cosmetics packaging market is advancing as organizations confront persistent threats from counterfeit products. Secure packaging is emerging as a critical control point, embedding value for companies committed to regulatory compliance, product integrity, and consumer trust across global supply chains.
Decision-makers increasingly acknowledge the significance of packaging not just for presentation but as a strategic driver of operational integrity, regulatory assurance, and brand credibility throughout regulated and retail channels. The market’s acceleration is fueled by complex supply chains and rising requirements for authenticity at every touchpoint.
Scope & Segmentation of the Market
- Authentication Technologies: Features such as covert and forensic markers, overt visual indicators, RFID/NFC systems for both passive and active verification, security inks like IR and thermochromic options, serialized barcodes and QR codes, and tamper-evident closures are central to multi-layered defense strategies.
- Material Choices: Options spanning glass, metals, a broad range of paper and board variants, and plastics including HDPE, PET, PP, PVC-all supporting distinct levels of integration and protection.
- Packaging Tiers: Primary components (blisters, vials, bottles, tubes), secondary layers (cartons, containers), and tertiary solutions (crates, pallets, pallet wraps) define functional points for security integration and influence the overall protective strategy.
- End-Use Segments: Specific considerations address cosmetics, from hair care to skincare and serums, alongside pharmaceuticals, spanning over-the-counter and prescription formats, each requiring compliance with different closure and regulatory norms.
- Geographic Coverage: Analysis covers the Americas; Europe, Middle East and Africa; and Asia-Pacific regions, each characterized by unique regulatory environments, climate variation, and supply chain distribution models.
Key Takeaways for Stakeholders
- Focused packaging initiatives are fundamental for protecting product authenticity, supporting verifiable transactions for both consumers and regulatory agencies.
- Deploying layered authentication-across overt, covert, and digital platforms-raises entry barriers for counterfeiters, enhancing traceability and reducing the risk of product diversion.
- Consensus on supplier standards and interoperable solutions allows for efficient rollout of compliant anti-counterfeit strategies across diverse markets.
- Manufacturing efficiency and secure packaging must be balanced, ensuring robust defense layers without disrupting throughput or the customer experience.
- Regional variations, such as differing regulations and logistical complexities, require packaging systems that can flexibly adapt while maintaining high security standards.
Why This Report Matters
- Enables leadership teams to prioritize investments in packaging solutions that deter counterfeit activity and align with evolving compliance requirements.
- Delivers actionable strategies for incorporating advanced technologies, structuring risk management, and driving supplier diversification to optimize resilience.
- Supports alignment of operational, regulatory, and consumer-facing objectives, strengthening overall supply chain security.
Conclusion
Anti-counterfeit pharmaceuticals and cosmetics packaging acts as a critical point of control for product protection. Embracing integrated, regionally responsive packaging strategies allows organizations to minimize risk, maintain assurance, and protect brand standing in a dynamic global environment.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2026 – 2032 |
| Estimated Market Value (USD) in 2026 | $113.52 Billion |
| Forecasted Market Value (USD) by 2032 | $288.22 Billion |
| Compound Annual Growth Rate | 16.6% |
| Regions Covered | Global |
Market Insights
- Consumer Insights & End-User Perspective
- Consumer Experience Benchmarking
- Opportunity Mapping
- Distribution Channel Analysis
- Pricing Trend Analysis
- Regulatory Compliance & Standards Framework
- ESG & Sustainability Analysis
- Disruption & Risk Scenarios
- Return on Investment & Cost-Benefit Analysis
Market Overview
- Introduction
- Industry Ecosystem & Value Chain Analysis
- Supply-Side Analysis
- Demand-Side Analysis
- Stakeholder Analysis
- Porter’s Five Forces Analysis
- PESTLE Analysis
- Market Outlook
- Near-Term Market Outlook (0-2 Years)
- Medium-Term Market Outlook (3-5 Years)
- Long-Term Market Outlook (5-10 Years)
- Go-to-Market Strategy
Companies Featured
- 3M Company
- AlpVision SA
- Antares Vision Group S.p.A.
- Applied DNA Sciences, Inc.
- Authentix Inc.
- Avery Dennison Corporation
- De La Rue plc
- Entrust Corporation
- Holostik India Limited
- Impinj, Inc.
- Markem-Imaje
- NXP Semiconductors N.V.
- OpSec Security Group plc
- OPTEL Group
- SICPA Holding SA
- Sproxil, Inc.
- Systech
- TraceLink, Inc.
- TruTag Technologies, Inc.
- Zebra Technologies Corporation
For more information about this report visit https://www.researchandmarkets.com/r/w6sry8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market
